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or other skin changes. The patient’s admission laboratory 
values were notable for a white blood cell count of 16,200 
cells/microliter (normal range 4,000-11,000) with 92% 
neutrophils (normal range 40-73%) and a hemoglobin of 
7.5 g/dl (normal 12.5-15) decreased from a baseline of 
9 g/dl. A chest x-ray was normal.
dIFFErEnTIal dIagnoSIS
The differential diagnosis for sudden vision loss is 
broad and can be divided into media disruptions, retinal 
problems, and neural visual pathway disturbances. 
Examples of media problems include keratitis, hyphema, 
lens changes, vitreous hemorrhage, uveitis, and 
endophthalmitis. Retinal pathology includes vascular 
occlusion, retinal detachment, and acute macular 
problems. Neural visual pathway disruptions can involve 
the optic nerve, chiasm, and retrochiasm.2 
InTroduCTIon
Catheter-related blood stream infections (CRBSIs) are a 
common and unfortunate consequence of prolonged 
vascular access in hemodialysis patients. Metastatic 
infections are feared sequelae of bacteremia, and 
include endocarditis, osteomyelitis, septic arthritis, 
epidural abscess, and endophthalmitis.1 The following 
is a case of Serratia endophthalmitis originating from a 
tunneled-dialysis catheter.
CaSE PrESEnTaTIon
A 47 year-old Caucasian female with a history of end 
stage renal disease on hemodialysis, Type 2 diabetes 
mellitus, and hypertension was undergoing her routinely 
scheduled hemodialysis session when she experienced 
“flashes of hot pink” in her left eye. The hemodialysis 
session was terminated, and the patient returned home. 
When she awoke the next morning she noticed a large 
black spot obscuring vision in her left eye as well as pain 
in the affected eye. The patient presented to Wills Eye 
Emergency Department that day. She denied any recent 
fevers, chills, pain, or erythema at the catheter site. She 
did, however, report that her left-sided chest wall tunneled 
dialysis catheter had been manipulated and tubing had 
been exchanged the day prior because of concerns that 
it was clogged. The patient was transferred to Thomas 
Jefferson University Hospital (TJUH) for further care.
Initial vital signs revealed a temperature of 98.6 degrees 
Fahrenheit, heart rate of 88 beats per minute, respiratory 
rate of 21 per minute, blood pressure of 160/94 mmHg, 
and 95% oxygen saturation on room air. Physical exam 
was significant for a diffusely erythematous left sclera 
with a hazy cornea and a small hypopion occupying the 
bottom third of the pupil (Figure 1). Her left pupil was 
sluggishly reactive to light. The patient’s visual acuity 
exam of the left eye revealed 20/60 vision (20/20 in right 
eye). Her left chest wall port site was non-erythematous 
with no palpable fluctuance or drainage. There was no 
tenderness to palpation in this area. Cardiac exam revealed 
a grade II/VI systolic ejection murmur most prominent 
at the right upper sternal border. There were crackles at 
both lung bases and bilateral 2+ lower extremity pitting 
edema to the shins. There were no splinter hemorrhages 
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Figure 1. Patient’s eye exam on day 3 of hospitalization, revealing 
significant hypopion and haziness of the cornea.
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ouTCoME and Follow-uP
The patient’s indwelling central venous access, elevated 
white blood cell count, and physical exam findings 
raised suspicion for an infectious cause of vision loss.  A 
culture of the patient’s vitreous fluid resulted as “many 
gram negative coccobacilli” five hours after being 
drawn, virtually clinching the diagnosis of bacterial 
endophthalmitis. The final culture revealed Serratia 
marcescens. Blood cultures drawn upon admission to 
TJUH grew gram negative bacilli one day after collection, 
and subsequently also speciated as Serratia marcescens. 
An ultrasound of the eye, also known as a “B scan”, 
was performed by Ophthalmology and showed a large 
subretinal abscess and dense vitritis. 
Her tunneled dialysis catheter was kept in place for 
48 hours to allow her to receive two more dialysis 
sessions due to concern for refractory fluid overload. 
Subsequently, the catheter was removed and she was 
given a three day line holiday before replacement once 
her blood cultures had cleared. Of note, cultures from 
the catheter tip also grew gram negative bacilli.
The patient was noted to have a systolic ejection murmur 
upon admission. It was unknown whether this was a new 
finding. Considering her evidence of metastatic infection, 
endocarditis was a concern (particularly involving the 
aortic valve). However, a transthoracic echocardiogram 
revealed no abnormalities involving the aortic valve or 
other vegetations. The patient’s murmur resolved with 
red blood cell transfusion, thus it was felt that her initial 
murmur was a flow murmur related to anemia. 
The patient was initially treated broadly with intraocular 
vancomycin, ceftazadime, moxifloxacin, and prednisolone, 
as well as intravenous vancomycin and piperacillin-
tazobactam. Oral moxifloxacin was added on day 3 for 
its vitreal penetration. Intravitreal tobramycin and atropine 
eye drops were also added on day 5. Sensitivities returned 
and subsequently the patient’s non-ocular antibiotics 
were de-escalated to only oral ciprofloxacin. 
Despite these interventions, the patient suffered 
progressive vision loss and eye swelling (Figure 2). Oral 
prednisone was added but did not significantly improve 
her ocular symptoms. Ten days after presentation, 
the patient underwent enucleation of her left eye for 
progressive swelling, pain, and fear of refractory ocular 
infection which could spread beyond the orbit. An ocular 
implant was inserted during the same surgery. She was 
discharged on both oral and ocular ciprofloxacin as well 
as ocular moxifloxacin and a Medrol dose pack.
Figure 2. Patient’s eye 7 days after admission. Notable are 
increased swelling, pus, worsening hypopion.
Figure 3. Structures of the eye. Endogenous endophthalmitis gains 
access to the eye through the choroid, the blood supply to the retina. 
http://www.harcourtcarteroptical.com/content2/anatomy
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dISCuSSIon
The most important modifiable risk factor for tunneled 
CRBSI is duration of catheter usage.3 One study found 
a 35% and 48% incidence of CRBSI at three and six 
months, respectively.3  The type of vascular access 
for hemodialysis patients also has an effect on the 
risk of infection. The relative risk of blood stream 
infection of a tunneled dialysis catheter compared 
with an arteriovenous fistula is 10:1. Additionally, the 
relative risk of a non-tunneled vs. tunneled dialysis 
catheter is 3:1.3 Other risk factors for CRBSIs include 
previous CRBSI, recent surgery, diabetes mellitus, iron 
overload, immunosuppression, and hypoalbuminemia.3 
Five techniques recommended by the Institute for 
Healthcare Improvement to prevent primary blood 
stream infections include effective hand hygiene, 
maximal barrier precautions at insertion, cutaneous 
antisepsis with chlorhexidine, optimal insertion site 
selection, and prompt removal when the catheter is no 
longer necessary.5  Microorganisms reach circulation 
in one of three ways: 1) colonization of insertion site 
(most common), 2) colonization of hubs, junctions, and 
other connectors—with subsequent access when these 
are manipulated, and 3) contamination of infused fluid.5 
Endophthalmitis is a potential metastatic complication 
of CRBSIs. Endophthalmitis refers to a bacterial or 
fungal infection within the eye, including involvement 
of the vitreous and/or aqueous humors.4 Of note, 
endophthalmitis is not caused by viruses or parasites; eye 
infections due to these organisms are termed “uveitis”. 
Endophthalmitis is further divided into exogenous and 
endogenous causes. Exogenous endophalmitis refers 
to infections that occur due to external factors such as 
trauma, surgery, or corneal infection. These account for 
the majority of cases of endophthalmitis. In contrast, 
endogenous endophthalmitis occurs due to seeding 
of the eye from within the body, typically through the 
choroid, which supplies blood to the retina.
KEy PoInTS
Catheter related blood stream infections are a common 
and often avoidable occurrence. The incidence of 
CRBSIs in end stage renal disease patients is directly 
related to the amount of time the catheter is left in 
place. CRBSIs should be suspected in any patient 
with central venous access who presents with fevers/
chills or any signs of metastatic infection. Endogenous 
endophthalmitis is a potential metastatic manifestation 
of a CRBSI. Urgent ophthalmic consultation, intraocular 
and systemic antibiotics/antifungals, as well as catheter 
removal are the mainstays of treatment.
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